• Price (USD)28.54
  • Today's Change1.31 / 4.81%
  • Shares traded1.37m
  • 1 Year change34.31%
  • Beta0.7723
Data delayed at least 15 minutes, as of May 27 2020 21:00 BST.
More ▼

Events & Activity

  • NEO:NAQ price moved over +3.23% to 29.09
  • NEO:NAQ price falls below 50-day moving average to 27.11 at 10:49 BST
  • NEO:NAQ price falls below 50-day moving average to 27.10 at 16:59 BST
  • NEO:NAQ trading volume exceeds daily average by +15.06%
  • NEO:NAQ price rises above 15-day moving average to 28.11 at 10:30 BST
  • NEO:NAQ price falls below 15-day moving average to 27.65 at 15:55 BST

Key statistics

On Wednesday, Neogenomics Inc (NEO:NAQ) closed at 28.54, -18.38% below its 52-week high of 34.97, set on Feb 18, 2020.
52-week range
18.52Oct 02 201934.97Feb 18 2020
Markit short selling activity
Previous close27.23
Average volume934.95k
Shares outstanding110.46m
Free float103.33m
P/E (TTM)855.21
Market cap3.01bn USD
EPS (TTM)0.0318
Data delayed at least 15 minutes, as of May 27 2020 21:00 BST.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.